Medical Rehabilitation Robotics Market

Medical Rehabilitation Robotics Market Size, Market Forecast and Outlook By FMI

The medical rehabilitation robotics market was valued at USD 0.6 billion in 2025. The market is set to reach USD 0.7 billion by 2026-end and grow at a CAGR of 15.3% between 2026-2036 to reach USD 2.7 billion by 2036. Exoskeleton Systems will dominate with a 40.0% share, while Upper Extremity will lead with a 70.0% share.

Medical Rehabilitation Robotics Market Overview: Size and Forecast

• Medical Rehabilitation Robotics Market Value (2026): USD 0.7 Bn
• Medical Rehabilitation Robotics Market Forecast Value (2036): USD 2.7 Bn
• Medical Rehabilitation Robotics Market Forecast CAGR (2026 to 2036): 15.3%
• Medical Rehabilitation Robotics Market Leading Product: Exoskeleton Systems (40.0%)
• Medical Rehabilitation Robotics Market Key Growth Regions: USA, UK, EU, Japan, South Korea
• Medical Rehabilitation Robotics Market Key Players: Ekso Bionics Holdings Inc., AlterG , Inc., Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Instead Technologies Ltd.

Parameter	Details
Market Size in 2026 (Value)	USD 0.7 Bn
Market Forecast in 2036 (Value)	USD 2.7 Bn
CAGR (2026 to 2036)	15.3%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD Bn)
Leading Sub-Region	EU

Summary of the Medical Rehabilitation Robotics Market

• Demand and Growth Drivers
  • Regulatory compliance requirements and hospital procurement cycles are expected to sustain demand for medical rehabilitation robotics products as healthcare facilities upgrade equipment to meet updated standards.
  • Aging population demographics across North America, Europe, and East Asia are projected to support steady adoption rates through the forecast period.
  • Cost containment pressure in institutional healthcare settings is shifting procurement toward products that reduce per-procedure costs and improve clinical throughput.
• Product and Segment View
  • Adult Patients is expected to account for 68.0% of the product segment in 2026, supported by established procurement patterns and end-use demand across commercial and institutional applications.
  • Therapeutic and Assistive Robots is projected to gain share during the forecast period as clinical applications expand across emerging markets and specialized use cases.
  • By therapy, Limb Mobility Therapy is expected to remain the primary demand driver, reflecting established consumption patterns and supply chain structures.
• Geography and Competitive Outlook
  • EU is projected to lead growth at 15.6% through 2036, supported by expanding healthcare infrastructure and regulatory frameworks.
  • South Korea at 15.4% reflects strong institutional demand and regulatory compliance culture during the forecast period.
  • Companies with established manufacturing footprints and direct procurement relationships across high-growth regions are positioned to capture incremental volume during the forecast period.
• Analyst Opinion
  • Anurag Sharma, Principal Consultant at FMI says, 'Companies that can align product portfolios with evolving regulatory requirements and institutional procurement standards are expected to strengthen market positioning through 2036.'
  • The medical rehabilitation robotics market is transitioning from a volume-driven phase into a value-driven phase where product performance, compliance readiness, and total cost of ownership are becoming primary procurement criteria.
  • The adoption is increasing owing to tightening of regulations, expansion of end-use sectors and replacement of legacy systems and products which no longer comply with updated specifications.
  • Also supporting demand is the consolidation of purchases by large-scale buyers, who prefer suppliers with integrated manufacturing and distribution capabilities.

Medical Rehabilitation Robotics Market Definition

The medical rehabilitation robotics market encompasses products, solutions, and services used across clinical, institutional, and commercial healthcare applications. The market covers all commercially traded medical rehabilitation robotics products classified by product, extremity, therapy, patient, application, end use, serving end-use sectors that require standardized performance, regulatory compliance, and supply reliability.

Medical Rehabilitation Robotics Market Inclusions

Market scope encompasses all commercially traded medical rehabilitation robotics products categorized by product (Exoskeleton Systems, Therapeutic and Assistive Robots), extremity (Upper Extremity, Lower Extremity), therapy (Limb Mobility Therapy, Gait Therapy, Sensory and Cognitive Therapy), patient (Adult Patients, Pediatric Patients, Research and Institutional Use), application (Neurorehabilitation, Physical Rehabilitation), end use (Hospitals, Wellness Centers, Rehabilitation Centers, Homecare Settings). Revenue estimates cover the period from 2026 to 2036 across all regions and distribution channels.

Medical Rehabilitation Robotics Market Exclusions

The scope does not include custom-engineered or one-off products outside standard commercial distribution, raw materials sold as unprocessed inputs, or services not directly tied to medical rehabilitation robotics product procurement and deployment.

Medical Rehabilitation Robotics Market Research Methodology

• Primary Research: FMI analysts conducted interviews with manufacturers, distributors, procurement specialists, and end-use operators across key markets to validate demand patterns and pricing structures.
• Desk Research: Combined trade data, regulatory filings, industry association publications, and manufacturer disclosures to establish baseline market parameters.
• Market Sizing and Forecasting: Bottom-up aggregation across product, extremity, and regional adoption curves, triangulated with top-down macro indicators.
• Data Validation: Cross-checked quarterly against production statistics, trade flow data, and manufacturer revenue disclosures.

Why is the Medical Rehabilitation Robotics Market Growing?

• Medical Rehabilitation Robotics products are facing sustained procurement demand across established and emerging markets driven by regulatory compliance upgrades and aging population demographics.
• The growth in the EU is 15.6% due to increasing institutional healthcare capacity and procurement of devices during the forecast period.
• The Adult Patients segment accounts for 68.0% of the product segment, with well-established demand patterns and extensive commercial applicability across clinical settings.

Medical Rehabilitation Robotics Market is expected to reach USD 0.7 Bn in 2026 and grow to USD 2.7 Bn by 2036, at a CAGR of 15.3% during the forecast period. The growth is being fueled by the expanding healthcare infrastructure, stringent regulatory requirements and wider use of standardized medical products in institutional settings. The incremental opportunity during 2026-2036 is attributed to the cumulative effect of replacement cycles, capacity additions and geographic expansion of procurement networks amounting to USD 2.1 Bn.

Adult Patients is the largest product segment with 68.0% in 2026. This segment’s demand is concentrated in hospital, clinic and laboratory settings where standardized product performance and regulatory approval are prerequisites for procurement. Therapeutic and Assistive Robots is a secondary growth category and gaining share as end-use applications extend to specialized and emerging use cases.

Growth in the EU is supported by increasing neurological rehabilitation demand, aging demographics, rehabilitation center modernization, and compliance with evolving medical device regulations. 15.4% South Korea shows MFDS regulatory pathways for medical devices. Demand is supported through replacement cycles, regulatory updates and institutional procurement in established markets in North America and Western Europe.

Market Segmentation Analysis

• Adult Patients is the largest product segment with 68.0% share in 2026, already witnessing established procurement trends in clinical and institutional use.
• Upper Extremity is the leading demand segment at the extremity level, with wide applicability across end-use segments.
• Therapy structures tend to mirror procurement channel preferences, with direct supply relationships being dictated by high-volume institutional demand.

The medical rehabilitation robotics market is segmented by product into lower extremity, upper extremity and therapy. The product segmentation is a reflection of the product taxonomy used in commercial procurement. Exoskeleton Systems, Therapeutic and Assistive Robots are the major product categories. Extremity segmentation captures differentiated demand across Upper Extremity, Lower Extremity.

Insights into the Exoskeleton Systems Segment

Exoskeleton Systems Product Segment is 40.0% in 2026 because there is an existing demand in hospital, clinic, and diagnosis. Powered Exoskeletons, Lower Limb Exoskeletons, Full Body Exoskeletons are some of the major sub-categories that serve for different end-use requirements.

Exoskeleton systems purchasing patterns depend on clinical protocol needs, reimbursement, and institutional purchasing cycles. The growth over the forecast period is expected to be a mirror of both replacement demand in established markets and capacity additions in emerging regions.

Insights into the Therapeutic and Assistive Robots Segment

Therapeutic and Assistive Robots is a product segment that is anticipated to grow, with an increasing number of applications in specialized clinical and diagnostic settings. Therapy Robots Upper Limb Therapy Robots Gait Training Robots The sub-categories include: * to meet the requirements of differentiated performance and compliance:

Clinical protocols are evolving, regulations are being updated and demand for precision-oriented products is growing, all of which are driving the increased use of therapeutic and assistive robots. The segment is anticipated to gain from new installations and upgrades to existing systems during the forecast period.

Medical Rehabilitation Robotics Market Drivers, Restraints, and Opportunities

• The key structural drivers of demand through 2036 are regulatory compliance, hospital modernization and aging demographics.
• Reimbursement constraints and pricing pressure from institutional procurement are the major demand-side restraints during the forecast period.
• Incremental procurement opportunities will be driven by emerging market healthcare expansion and point-of-care adoption.

The medical rehabilitation robotics market is set to experience a sustained procurement environment through 2036, driven by structural demand drivers, regulatory mandates, and the expansion of end-use sectors. Restraints include input cost pressures, supply chain concentration risks, and regulatory compliance costs that limit adoption in price-sensitive segments of the market.

Regulatory and Compliance-Driven Procurement

Demand is driven by changing regulatory requirements in the FDA, EU MDR and regional medical device regulations. Product specification changes, label requirements, and post-market surveillance requirements create recurring procurement cycles as manufacturers and health care facilities comply with revised standards .

Institutional Replacement and Modernization Cycles

Drivers: Aging installed bases in hospital and laboratory settings across North America, Europe and East Asia are driving this. Demand is expected to be strong for facilities replacing legacy systems and products in order to meet new safety, efficiency and interoperability standards during the period.

Emerging Market Healthcare Expansion

Investments in health care infrastructure in China, India and Southeast Asia are driving the adoption. Government programs, private hospital expansion and expanding insurance coverage are creating new procurement channels for standardized medical products and devices.

Analysis of Medical Rehabilitation Robotics Market By Key Countries

Country	CAGR
EU	15.6%
South Korea	15.4%
USA	15.1%
Japan	15.0%
UK	14.8%

• EU at 15.6% reflects EU MDR regulatory transition driving device re-certification.
• South Korea at 15.4% reflects advanced hospital infrastructure and high device adoption.
• USA at 15.1% reflects Medicare and Medicaid reimbursement structures.
• Japan at 15.0% reflects domestic OEM quality standards and long qualification cycles.

The global medical rehabilitation robotics market is projected to expand at 15.3% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

Demand Outlook for Medical Rehabilitation Robotics Market in EU

The demand for medical rehabilitation robotics in EU is focused on institutional healthcare and diagnosis. The market is expected to grow with a CAGR of 15.6% till 2036. The growth is fueled by device re-certification due to the EU MDR regulatory transition and centralized procurement across hospital systems of the member state.

• Procurement demand for exoskeleton systems is growing in clinical and institutional channels as devices are re-certified under the EU MDR regulatory transition.
• Centralized procurement across member state hospital systems supports the adoption of therapeutic and assistive robots as end-use requirements increase.
• Strong emphasis on clinical effectiveness, rehabilitation outcomes, and adherence to medical device quality standards is expected to support wider adoption of upper extremity rehabilitation robotics across hospitals and specialized rehabilitation centers during the forecast period.

Future Outlook for Medical Rehabilitation Robotics Market in South Korea

The MFDS regulatory pathways for medical devices in South Korea and the market is growing at 15.4% through 2036 creating sustained procurement demand for medical rehabilitation robotics. Adoption across end-use sectors is further supported by advanced hospital infrastructure and high device adoption.

• The MFDS regulatory paths for medical devices are spurring procurement demand for exoskeleton systems in clinical and institutional channels.
• Advanced hospital infrastructure and high device adoption supports adoption of therapeutic and assistive robots as end-use requirements expand.
• Domestic OEM positions in precision manufacturing is expected to create incremental volume for upper extremity applications over the forecast period.

Opportunity Analysis of Medical Rehabilitation Robotics Market in USA

Healthcare infrastructure of USA is conducive to growth rate of 15.1% through 2036. Procurement pathways are based on FDA regulatory pathways and 510(k) clearances and Medicare and Medicaid reimbursement structures.

• FDA regulatory pathways and 510(k) clearances is fueling procurement demand for exoskeleton systems across clinical and institutional channels.
• Rising demand for post-stroke rehabilitation, spinal cord injury treatment, and growing adoption of advanced robotic therapy systems support market growth.
• The upper extremity applications are expected to offer incremental volume during the forecast period owing to the reimbursement structures of Medicare and Medicaid.

In-depth Analysis of Medical Rehabilitation Robotics Market in Japan

Japanese regulatory requirements are driving demand for medical rehabilitation robotics, and the market is expected to grow at a CAGR of 15.0% through 2036. Demand-side drivers include extended device demand from an aging population and hospital automation and precision care investment.

• Regulatory pathways for the PMDA and Shonin approvals are driving demand for procurement of exoskeleton systems in clinical and institutional channels.
• As the population ages, the increasing demand for devices supports the adoption of therapeutic and assistive robots as the end-use requirements expand.
• Hospital automation and investment in precision care are anticipated to generate incremental volume for upper extremity applications, during the forecast period.

Sales Analysis of Medical Rehabilitation Robotics Market in UK

UK Infrastructure Investment to Support Demand at 14.8% - Medical Rehabilitation Robotics Market forecast to 2036 Growth is driven by NHS procurement frameworks, NICE assessments and post-Brexit regulatory alignment with MHRA pathways.

• Exoskeleton systems are being pulled through NHS procurement frameworks and NICE assessments across clinical and institutional channels.
• The adoption of therapeutic and assistive robots is supported by alignment with MHRA pathways post-Brexit as the end-use requirements expand.
• The aging population demographics driving device demand are expected to generate incremental volume for upper extremity applications during the forecast period.

Competitive Landscape and Strategic Positioning

• Ekso Bionics, Hocoma AG, Cyberdyne Inc., and Lifeward are among the leading participants in the global medical rehabilitation robotics market.
• Hocoma AG, Inc., Bionik Laboratories Corp., Cyberdyne Inc. maintain competitive positions through product portfolio breadth and clinical validation capabilities.
• Emerging players are focusing on specialized clinical applications and point-of-care segments to gain market entry.

Ekso Bionics Holdings Inc. leads the medical rehabilitation robotics market through broad product portfolios, regulatory approvals across multiple jurisdictions, and established relationships with hospital and laboratory procurement. Hocoma AG, maintains a competitive position through clinical product specialization and diagnostic technology capabilities.

Bionik Laboratories Corp. and Cyberdyne Inc. compete on product performance, regulatory compliance, and clinical evidence. Competitive barriers include regulatory approval timelines, clinical validation requirements, and established GPO relationships.

Strategic priorities include expanding product portfolios into adjacent clinical applications, securing regulatory approvals in emerging markets, and improving manufacturing cost structures.

Key Companies in the Medical Rehabilitation Robotics Market

Key global companies leading the medical rehabilitation robotics market include:

• Ekso Bionics Holdings Inc., Hocoma AG, Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics maintain leading positions through established manufacturing infrastructure, broad product portfolios, and direct procurement relationships across global markets.
• Fourier Intelligence have built competitive positions in regional markets through specialized product capabilities and focused distribution networks.

Competitive Benchmarking: Medical Rehabilitation Robotics Market

Company	Product Portfolio	Regulatory Coverage	Clinical Evidence	Geographic Reach
Ekso Bionics Holdings Inc.	High	High	Strong	Global
Hocoma AG	High	High	Strong	Global
Bionik Laboratories Corp.	Medium	Medium	Moderate	Regional
Cyberdyne Inc.	Medium	Medium	Moderate	Regional
ReWalk Robotics	Medium	Medium	Moderate	Regional
Fourier Intelligence	Medium	Medium	Low	Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Medical Rehabilitation Robotics Market

• In 2025, Ekso Bionics Holdings Inc. expanded its medical rehabilitation robotics product portfolio to address updated regulatory requirements and clinical demand across North America and Europe.
• In 2025, AlterG , Inc. secured regulatory clearance for a new exoskeleton systems configuration targeting institutional healthcare applications in high-growth markets.

Key Players in the Medical Rehabilitation Robotics Market

Major Global Players

• Ekso Bionics Holdings Inc.
• Hocoma AG
• Bionik Laboratories Corp.
• Cyberdyne Inc.
• ReWalk Robotics
• Fourier Intelligence

Emerging Players/Startups

• Fourier Intelligence
• Wandercraft
• Marsi Bionics
• Rex Bionics
• Neofect

Medical Rehabilitation Robotics Market - Research Methodology

Method	Description
Primary Research	FMI analysts conducted interviews with manufacturers, distributors, procurement specialists, and end-use operators across key markets to validate demand patterns and pricing structures.
Desk Research	Combined trade data, regulatory filings, industry association publications, and manufacturer disclosures to establish baseline market parameters.
Market Sizing & Forecasting	Bottom-up aggregation across product, extremity, and regional adoption curves, triangulated with top-down macro indicators.
Data Validation	Cross-checked quarterly against production statistics, trade flow data, and manufacturer revenue disclosures.

Report Scope and Coverage

Parameter	Details
Market size by 2036	USD 2.7 Bn
Growth rate	15.3% CAGR (2026 to 2036)
Forecast period	2026 to 2036
Base year value (2025)	USD 0.6 Bn
Key Segment Covered	Product, Extremity, Therapy, Patient, Application, End Use
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, South Korea, Japan, UK, 30 plus countries
Key companies profiled	Ekso Bionics Holdings Inc., Hocoma AG, Bionik Laboratories Corp., Cyberdyne Inc., ReWalk Robotics, Fourier Intelligence

Market Segmentation Analysis

Medical Rehabilitation Robotics Market Segmented by Product:

• Exoskeleton Systems
  • Powered Exoskeletons
    • Lower Limb Exoskeletons
    • Full Body Exoskeletons
  • Passive Exoskeletons
    • Upper Body Support Systems
    • Rehabilitation Assist Devices
• Therapeutic and Assistive Robots
  • Therapy Robots
    • Upper Limb Therapy Robots
    • Gait Training Robots
  • Assistive Robots
    • Daily Living Assist Robots
    • Mobility Support Robots

Medical Rehabilitation Robotics Market Segmented by Extremity:

• Upper Extremity
  • Shoulder Rehabilitation
    • Active Motion Therapy
    • Passive Motion Therapy
  • Hand and Wrist Rehabilitation
    • Grip Strength Training
    • Fine Motor Skill Recovery
• Lower Extremity
  • Hip and Knee Rehabilitation
    • Weight Bearing Systems
    • Range of Motion Therapy
  • Ankle and Foot Rehabilitation
    • Gait Assistance
    • Balance Training

Medical Rehabilitation Robotics Market Segmented by Therapy:

• Limb Mobility Therapy
  • Upper Limb Mobility
    • Arm Rehabilitation
    • Hand Rehabilitation
  • Lower Limb Mobility
    • Leg Movement Therapy
    • Joint Mobility Therapy
• Gait Therapy
  • Treadmill Based Training
    • Body Weight Support Systems
    • Robotic Gait Trainers
  • Overground Training
    • Wearable Exoskeleton Training
    • Assisted Walking Systems
• Sensory and Cognitive Therapy
  • Sensory Feedback Therapy
    • Haptic Feedback Systems
    • Virtual Reality Integration
  • Cognitive Rehabilitation
    • Neuroplasticity Training
    • Brain Computer Interface Therapy

Medical Rehabilitation Robotics Market Segmented by Patient:

• Adult Patients
  • Geriatric Patients
    • Age Related Mobility Disorders
    • Post Stroke Rehabilitation
  • Non Geriatric Adults
    • Injury Rehabilitation
    • Neurological Conditions
• Pediatric Patients
  • Neurodevelopmental Disorders
    • Cerebral Palsy Rehabilitation
    • Developmental Delay Therapy
  • Pediatric Injury Recovery
    • Orthopedic Rehabilitation
    • Post Surgical Recovery
• Research and Institutional Use
  • Pharmaceutical and Biotechnology Companies
    • Clinical Trials Support
    • Drug Rehabilitation Studies
  • Academic and Research Institutes
    • Robotics Research
    • Therapy Innovation

Medical Rehabilitation Robotics Market Segmented by Application:

• Neurorehabilitation
  • Stroke Rehabilitation
    • Upper Limb Recovery
    • Gait Recovery
  • Spinal Cord Injury Rehabilitation
    • Mobility Restoration
    • Functional Independence Training
• Physical Rehabilitation
  • Orthopedic Rehabilitation
    • Post Surgery Recovery
    • Joint Replacement Therapy
  • Sports Injury Rehabilitation
    • Muscle Strength Recovery
    • Range of Motion Improvement

Medical Rehabilitation Robotics Market Segmented by End Use:

• Hospitals
  • Acute Care Hospitals
    • Neurology Departments
    • Orthopedic Departments
  • Specialty Hospitals
    • Rehabilitation Units
    • Advanced Therapy Centers
• Wellness Centers
  • Physiotherapy Centers
    • Outpatient Therapy
    • Preventive Rehabilitation
  • Fitness and Recovery Centers
    • Post Injury Conditioning
    • Mobility Enhancement
• Rehabilitation Centers
  • Inpatient Rehabilitation Facilities
    • Long Term Therapy
    • Neurological Rehabilitation
  • Outpatient Rehabilitation Centers
    • Day Care Therapy
    • Post Acute Care
• Homecare Settings
  • Home Based Rehabilitation
    • Portable Robotic Devices
    • Remote Monitoring Systems
  • Tele Rehabilitation
    • Connected Therapy Systems
    • Virtual Therapy Platforms

Medical Rehabilitation Robotics Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• World Health Organization (WHO). (2025). Global Report on Assistive Technology and Rehabilitation Services. WHO.
• USA Food and Drug Administration (FDA). (2025). Medical Device Databases, 510(k) Clearances, and Rehabilitation Robotics Regulatory Documentation. FDA.
• International Medical Device Regulators Forum (IMDRF). (2025). Medical Device Regulatory Frameworks and Market Access Guidance. IMDRF.
• International Industry Society in Advanced Rehabilitation Technology (IISART). (2025). Industry Resources on Rehabilitation Robotics, Therapeutic Electrical Stimulation, and Advanced Rehabilitation Technologies.
• Frontiers in Robotics and AI. (2025). Rehabilitation Robotics and Allied Digital Technologies: Opportunities, Barriers and Solutions for Clinical Implementation.

This bibliography is provided for reader reference.

This Report Answers

• Estimating the size of the medical rehabilitation robotics market and revenue projections from 2026 to 2036.
• Segmentation by product, extremity, therapy, patient, application, end use.
• Insights across more than 30 regional and country-level markets.
• Analysis of clinical adoption, regulatory landscape, and institutional procurement patterns.
• Assessment of the competitive landscape and company benchmarking.
• Identification of growth opportunities across product and extremity segments.
• Evaluation of supply chain dynamics and distribution channel structures.
• Delivery of data in PDF and Excel formats.